Human ena/VASP-like protein splice variant
US6645499B1 · kind B1 · utility
84Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 1999 |
| Grant date | Nov 11, 2003 |
| Priority date | — |
| Expiry date | Sep 1, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides a human ena/VASP-like protein splice variant (EVL1) and polynucleotides which identify and encode EVL1. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of EVL1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.